• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用机器学习模型分析亚洲国家疫苗接种对新冠病例和死亡的影响。

Analyzing the Effect of Vaccination Over COVID Cases and Deaths in Asian Countries Using Machine Learning Models.

机构信息

Molecular Biology Research Lab., Department of Zoology, Deshbandhu College, University of Delhi, New Delhi, India.

Department of Computer Science, Deshbandhu College, University of Delhi, New Delhi, India.

出版信息

Front Cell Infect Microbiol. 2022 Feb 8;11:806265. doi: 10.3389/fcimb.2021.806265. eCollection 2021.

DOI:10.3389/fcimb.2021.806265
PMID:35223534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8877421/
Abstract

Coronavirus Disease 2019 (COVID-19) is spreading across the world, and vaccinations are running parallel. Coronavirus has mutated into a triple-mutated virus, rendering it deadlier than before. It spreads quickly from person to person by contact and nasal or pharyngeal droplets. The COVID-19 database 'Our World in Data' was analyzed from February 24, 2020, to September 26, 2021, and predictions on the COVID positives and their mortality rate were made. Factors such as Vaccine data for the First and Second Dose vaccinated individuals and COVID positives that influence the fluctuations in the COVID-19 death ratio were investigated and linear regression analysis was performed. Based on vaccination doses (partial or complete vaccinated), models are created to estimate the number of patients who die from COVID infection. The estimation of variance in the datasets was investigated using Karl Pearson's coefficient. For COVID-19 cases and vaccination doses, a quartic polynomial regression model was also created. This predictor model helps to predict the number of deaths due to COVID-19 and determine the susceptibility to COVID-19 infection based on the number of vaccine doses received. SVM was used to analyze the efficacy of models generated.

摘要

2019 年冠状病毒病(COVID-19)正在全球范围内蔓延,疫苗接种工作也在同时进行。冠状病毒已经突变成为三重突变病毒,其致命性比以前更高。它通过接触和鼻或咽飞沫在人与人之间迅速传播。从 2020 年 2 月 24 日到 2021 年 9 月 26 日,对 COVID-19 数据库“我们的世界数据”进行了分析,并对 COVID 阳性病例及其死亡率进行了预测。研究了影响 COVID-19 死亡率波动的因素,如第一和第二剂疫苗接种人群的数据和 COVID 阳性病例,并进行了线性回归分析。基于疫苗接种剂量(部分或完全接种),创建了模型来估计因 COVID 感染而死亡的患者人数。使用 Karl Pearson 系数研究了数据集的方差估计。对于 COVID-19 病例和疫苗接种剂量,还创建了一个四次多项式回归模型。该预测模型有助于预测 COVID-19 死亡人数,并根据接种疫苗的剂量来确定对 COVID-19 感染的易感性。SVM 用于分析生成模型的效果。

相似文献

1
Analyzing the Effect of Vaccination Over COVID Cases and Deaths in Asian Countries Using Machine Learning Models.使用机器学习模型分析亚洲国家疫苗接种对新冠病例和死亡的影响。
Front Cell Infect Microbiol. 2022 Feb 8;11:806265. doi: 10.3389/fcimb.2021.806265. eCollection 2021.
2
Evaluation of a COVID-19 Vaccine Campaign and SARS-CoV-2 Infection and Mortality Among Adults Aged 60 Years And Older in a Middle-Income Country.评估 COVID-19 疫苗接种活动以及中低收入国家 60 岁及以上成年人中的 SARS-CoV-2 感染和死亡率。
JAMA Netw Open. 2021 Oct 1;4(10):e2130800. doi: 10.1001/jamanetworkopen.2021.30800.
3
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
4
Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.当在丹麦将第一剂 ChAdOx1 疫苗与随后的 mRNA 疫苗相结合时,针对 SARS-CoV-2 感染、住院和死亡的疫苗有效性:一项全国范围内基于人群的队列研究。
PLoS Med. 2021 Dec 17;18(12):e1003874. doi: 10.1371/journal.pmed.1003874. eCollection 2021 Dec.
5
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
6
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.在真实环境中评估灭活 COVID-19 疫苗诱导的 SARS-CoV-2 特异性体液和细胞免疫应答的特征。
Front Immunol. 2021 Dec 22;12:802858. doi: 10.3389/fimmu.2021.802858. eCollection 2021.
7
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.BNT162b2 新冠病毒疫苗与体液免疫应答及动力学的相关性:医护人员前瞻性、单中心、纵向队列研究。
Lancet Respir Med. 2021 Sep;9(9):999-1009. doi: 10.1016/S2213-2600(21)00220-4. Epub 2021 Jul 2.
8
Predictive Modeling of Vaccination Uptake in US Counties: A Machine Learning-Based Approach.基于机器学习的美国县疫苗接种率预测模型。
J Med Internet Res. 2021 Nov 25;23(11):e33231. doi: 10.2196/33231.
9
Individual preferences for COVID-19 vaccination in China.中国人对 COVID-19 疫苗接种的个体偏好。
Vaccine. 2021 Jan 8;39(2):247-254. doi: 10.1016/j.vaccine.2020.12.009. Epub 2020 Dec 5.
10
[Antibody Response After Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: A Prospective Observational Study].[既往感染过新冠病毒与未感染过新冠病毒的医护人员接种两剂新冠病毒灭活疫苗后的抗体反应:一项前瞻性观察研究]
Mikrobiyol Bul. 2022 Jan;56(1):36-48. doi: 10.5578/mb.20229904.

引用本文的文献

1
Machine learning insights on the effectiveness of non-pharmaceutical interventions against COVID-19 in Nigeria.机器学习对尼日利亚非药物干预措施抗击新冠肺炎有效性的见解。
Int Health. 2025 Sep 3;17(5):809-819. doi: 10.1093/inthealth/ihae065.
2
A protocol for modeling the factors influencing the deployment of the COVID-19 vaccine across African countries.一种用于建模影响非洲国家 COVID-19 疫苗接种部署的因素的方案。
PLoS One. 2024 Nov 7;19(11):e0311800. doi: 10.1371/journal.pone.0311800. eCollection 2024.
3
Outcome prediction in hospitalized COVID-19 patients: Comparison of the performance of five severity scores.

本文引用的文献

1
Clinical features and mechanistic insights into drug repurposing for combating COVID-19.对抗 COVID-19 的药物再利用的临床特征和机制见解。
Int J Biochem Cell Biol. 2022 Jan;142:106114. doi: 10.1016/j.biocel.2021.106114. Epub 2021 Nov 5.
2
Genomic Variations in the Structural Proteins of SARS-CoV-2 and Their Deleterious Impact on Pathogenesis: A Comparative Genomics Approach.SARS-CoV-2 结构蛋白的基因组变异及其对发病机制的有害影响:一种比较基因组学方法。
Front Cell Infect Microbiol. 2021 Oct 13;11:765039. doi: 10.3389/fcimb.2021.765039. eCollection 2021.
3
The role of COVID-19 survivor status and gender towards neutralizing antibody titers 1, 2, 3 months after Sinovac vaccine administration on clinical-year medical students in Indonesia.
住院COVID-19患者的预后预测:五种严重程度评分的性能比较。
Front Med (Lausanne). 2023 Feb 8;10:1121465. doi: 10.3389/fmed.2023.1121465. eCollection 2023.
新型冠状病毒肺炎幸存者状态和性别对印度尼西亚临床医学生接种科兴疫苗后 1、2、3 个月中和抗体滴度的影响。
Int J Infect Dis. 2021 Dec;113:336-338. doi: 10.1016/j.ijid.2021.10.009. Epub 2021 Oct 12.
4
A global database of COVID-19 vaccinations.一个全球 COVID-19 疫苗接种数据库。
Nat Hum Behav. 2021 Jul;5(7):947-953. doi: 10.1038/s41562-021-01122-8. Epub 2021 May 10.
5
Knowledge, Attitude, and Practice in Indonesian Health Care Workers Regarding COVID-19.印度尼西亚医护人员对COVID-19的知识、态度和实践。
Asia Pac J Public Health. 2021 Jul;33(5):662-664. doi: 10.1177/10105395211011017. Epub 2021 Apr 19.
6
Guidelines and Safety Considerations in the Laboratory Diagnosis of SARS-CoV-2 Infection: A Prerequisite Study for Health Professionals.2019冠状病毒病感染实验室诊断的指南与安全考量:卫生专业人员的一项前提研究
Risk Manag Healthc Policy. 2021 Feb 3;14:379-389. doi: 10.2147/RMHP.S284473. eCollection 2021.
7
Emerging Therapeutic Approaches to COVID-19.新冠病毒治疗新进展
Curr Pharm Des. 2021 Oct 5;27(31):3370-3388. doi: 10.2174/1381612827666210125160703.
8
Sputnik V COVID-19 vaccine candidate appears safe and effective.“卫星V”新冠疫苗候选产品似乎安全有效。
Lancet. 2021 Feb 20;397(10275):642-643. doi: 10.1016/S0140-6736(21)00191-4. Epub 2021 Feb 2.
9
Efficacy and Safety of Tocilizumab for Coronavirus Disease 2019 (Covid-19) Patients: A Systematic Review and Meta-analysis.托珠单抗治疗 2019 冠状病毒病(COVID-19)患者的疗效和安全性:系统评价和荟萃分析。
Drug Res (Stuttg). 2021 May;71(5):265-274. doi: 10.1055/a-1336-2371. Epub 2021 Jan 5.
10
Role of Mass Media and Public Health Communications in the COVID-19 Pandemic.大众媒体与公共卫生传播在新冠疫情中的作用
Cureus. 2020 Sep 14;12(9):e10453. doi: 10.7759/cureus.10453.